Solicitation, total small business set-aside
Proteomic analysis of human plasma samples from cancer patients
75F40124R00085
Food and Drug Administration, FDA National Center for Toxicological Research. Testing Laboratories and Services.
Awarded
$99,413.00 obligated so far on USAspending
Description
As published on SAM.gov.
Title: Proteomic analysis of human plasma samples from cancer patients Questions due 12PM EST July 05, 2023 Proposal due 12PM EST July 14, 2023
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Olink Proteomics Inc.
- UEI
- LY8PXLZYEXL7
- CAGE
- 9ASQ1
- Vendor location
- Waltham, MA
- Contract
- 75F40124P00440, purchase order
- Obligated
- $99,413.00
- Actions
- 2 between September 4, 2024 and December 6, 2024
- Competition
- Competed Under SAP, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Cardiotoxicity Biomarker Analysis for Plasma Samples from Cancer Patients
- Match
- solicitation number 75F40124R00085 equals the FPDS solicitation identifier; same sub-agency 7524 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 21, 2024
Solicitation
Due July 14, 2024 at 12:00 PM EDT. SAM.gov, notice 31fb18fd981e470fba1415c1071addc3
Points of contact
- Ryan Alexanderryan.alexander@fda.hhs.gov